The peptide & supplement tracking library

CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH) discussed in recovery, sleep, and body-composition contexts, frequently paired with ipamorelin. It is not an approved medication; human evidence is limited.

Ipamorelin is a selective growth-hormone secretagogue often discussed alongside CJC-1295. It is not approved; human data are limited.

Tesamorelin (Egrifta) is the only FDA-approved GHRH analog, approved specifically for HIV-associated lipodystrophy. It is sometimes discussed more broadly for visceral fat; that broader use is off-label and a clinician-level decision.

Sermorelin is a GHRH analog historically used to assess growth-hormone deficiency and now common in wellness/longevity clinics via compounding. It is usually framed as a gentler secretagogue; it is still clinician-territory.

AOD-9604 is a fragment of the growth-hormone molecule marketed in fat-loss contexts. It is not approved, and clinical fat-loss evidence in humans is weak. Worth a frank clinician conversation about whether it adds anything over fundamentals.

MOTS-c is a mitochondrial-derived peptide studied in metabolism and exercise-physiology research. Human clinical evidence is early; it is not an approved medication.

BPC-157 is a synthetic peptide widely discussed for soft-tissue and gut recovery. It has not been approved for human use and lacks completed human clinical trials. Anyone considering it should discuss legality, sourcing, and safety directly with a clinician.

TB-500 is a peptide fragment discussed in injury-recovery communities, often alongside BPC-157. It is not approved for human use and human data are sparse. Clinician guidance is essential.

GHK-Cu is a copper-binding peptide. In topical skincare it is mainstream and regulated as a cosmetic. Injectable use is a different, unapproved risk category and needs clinician oversight.

Melanotan II is an unapproved melanocortin-receptor agonist marketed for tanning and libido effects. It is unregulated, and there are documented safety concerns, including reports of new or changing moles/melanoma during or after use.

Thymosin Alpha-1 is a naturally occurring peptide discussed in immune-modulation contexts. It is not FDA-approved in the US; human evidence for wellness use is limited, and any use should be clinician-directed.

Thymosin Beta-4 is a naturally occurring peptide discussed in tissue-repair contexts and closely related to the marketed TB-500 fragment. It is not approved for human use and human data are sparse — clinician guidance is essential.

SS-31 (elamipretide) is an investigational mitochondria-targeting peptide studied in specific disease trials. It is not an approved medication, and general wellness evidence is not established.

Epitalon is a synthetic peptide discussed in longevity and sleep/circadian contexts. It is not approved for human use, and robust human evidence is lacking — a frank clinician conversation is warranted.

DSIP is a naturally occurring peptide discussed in sleep and stress-response contexts. It is not approved for human use, and human data are limited — track sleep honestly and involve a clinician.

KPV is a short peptide discussed in inflammation and gut-comfort contexts. It is not approved for human use, and human evidence is limited — clinician guidance is essential.

LL-37 is a naturally occurring antimicrobial peptide studied in immune and wound-context research. It is not approved for human use, and supplemental-use evidence is limited — clinician guidance is essential.

Selank is a synthetic peptide discussed in anxiety and cognition contexts. It is not FDA-approved, and human evidence outside a small research base is limited — clinician guidance is essential.

Semax is a synthetic peptide discussed in cognition and focus contexts, commonly used intranasally. It is not FDA-approved, and human evidence outside a limited research base is small — clinician guidance is essential.

IGF-1 LR3 is a modified insulin-like growth factor discussed in muscle-growth contexts. It is not approved for human use and carries real safety concerns — this entry exists to inform, not to guide use.

Hexarelin is a growth-hormone secretagogue discussed alongside other GH peptides. It is not approved for human use; human data are limited and GH-axis effects warrant clinician oversight.

GHRP-2 is a growth-hormone-releasing peptide discussed for recovery and body composition, often alongside a GHRH analog. It is not approved for human use; human data are limited.

GHRP-6 is a growth-hormone-releasing peptide known for a strong hunger effect, discussed for recovery and body composition. It is not approved for human use; human data are limited.

Kisspeptin is a naturally occurring peptide central to reproductive-hormone signaling and studied in fertility research. It is not an approved medication; wellness-use evidence is not established.